Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes

Le Roux, CW, Lau, DCW, Fujioka, K, Greenway, F, Wilding, JPH ORCID: 0000-0003-2839-8404, Jacobsen, PB, Skjoth, T and Madsbad, S (2017) Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes. .

Text M:\Word\Clinical Trials\NOVO\SCALE OBESITY\Le Roux DUK abstract 2017 Early weight loss responders to liraglutide 3.docx - Author Accepted Manuscript Download (13kB)